358570 — GI Innovation Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,238	129,968	64,292	44,730	15,411
Net Total Accounts Receivable
Net Total Receivables	225	1,691	4,890	1,983	1,725
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15,948	134,197	72,862	48,195	19,841
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,561	11,477	11,353	8,607	6,145
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	59,427	179,868	106,335	81,340	45,771
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	169,028	5,243	6,632	5,796	4,720
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	171,787	9,437	10,688	9,636	16,721
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	-112,360	170,431	95,646	71,704	29,051
Total Liabilities & Shareholders' Equity	59,427	179,868	106,335	81,340	45,771
Total Common Shares Outstanding